Femasys Inc. Files 8-K Report
Ticker: FEMY · Form: 8-K · Filed: Aug 20, 2025 · CIK: 1339005
| Field | Detail |
|---|---|
| Company | Femasys Inc (FEMY) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Femasys filed an 8-K on Aug 20, 2025 - check for updates.
AI Summary
On August 20, 2025, Femasys Inc. filed a Form 8-K to report other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates that Femasys Inc. has submitted a current report to the SEC, which may contain material updates for investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain specific financial or operational details that would indicate a high risk.
Key Players & Entities
- Femasys Inc. (company) — Registrant
- August 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 30024 (zip_code) — Business address zip code
- 770-500-3910 (phone_number) — Business phone number
FAQ
What specific events are being reported in this 8-K filing?
The provided text indicates the filing is for 'Other Events' and 'Financial Statements and Exhibits', but does not specify the details of these events.
When was this 8-K report filed?
The report was filed on August 20, 2025.
What is Femasys Inc.'s principal executive office address?
The principal executive offices are located at 3950 Johns Creek Court, Suite 100, Suwanee, Georgia 30024.
What is Femasys Inc.'s IRS Employer Identification Number?
The IRS Employer Identification Number for Femasys Inc. is 11-3713499.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 443 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2025-08-20 09:16:11
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share FEMY The Nasdaq Stock Mar
Filing Documents
- ef20054250_8k.htm (8-K) — 30KB
- ef20054250_ex99-1.htm (EX-99.1) — 14KB
- image00001.jpg (GRAPHIC) — 3KB
- 0001140361-25-032014.txt ( ) — 184KB
- femy-20250820.xsd (EX-101.SCH) — 4KB
- femy-20250820_lab.xml (EX-101.LAB) — 22KB
- femy-20250820_pre.xml (EX-101.PRE) — 16KB
- ef20054250_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events On August 20, 2025, Femasys Inc. (the "Company") issued a press release announcing that Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Femasys Inc. dated August 20, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Femasys Inc. By: /s/ Kathy Lee-Sepsick Names: Kathy Lee-Sepsick Title: Chief Executive Officer Date: August 20, 2025